Xconomy Forum: Seattle Life Sciences 2029***SOLD OUT***

Seattle biotech has taken its share of lumps lately, but beyond the next quarter or next year, what kind of life sciences potential really exists here in the Northwest? What will the Seattle life sciences landscape look like 20 years from now? Will the region have grown as a world leader in university and corporate research, venture financing, and entrepreneurial activity? Which particular fields of life sciences and healthcare will be the most vibrant? We will bring together a select group of innovators and visionaries in the heart of Seattle’s South Lake Union neighborhood for an intimate, interactive discussion of these and other key questions about the future of Seattle-area life sciences.

Opening Remarks:
Ken Stuart, President & Director, Seattle Biomedical Research Institute
Chris Rivera, President, Washington Biotechnology & Biomedical Association

Special Video Message:
Leroy Hood, President, Institute for Systems Biology

Panelists:

  • Carl Weissman (moderator), CEO, Accelerator Corporation, Managing Director, OVP Venture Partners
  • Steve Gillis, Managing Director, ARCH Venture Partners
  • Ben Shapiro, former EVP of Basic Research at Merck
  • Stephen Friend, CEO and Co-founder, Sage Bionetworks

Bonus Feature:
Meet top executives from emerging life sciences startups, who will provide brief introductions to their companies.

  • Calistoga Pharmaceuticals
  • Immune Design
  • VentiRx
  • VLST

Schedule:
Registration: 5:30 – 6:00 pm
Program: 6:00 – 7:30 pm
Networking reception: 7:30 – 8:00 pm

Registration:
Early Bird Registration – $90.00 (Available until September 30)
Regular Registration – $125.00
Student Registration – $25 (Limited number available. Valid student ID must be shown at registration desk.)
At the door – $150.00

Tickets are transferable but not refundable.

To inquire about press registration, email events@xconomy.com.

.Register Now

HOSTED BY

SBRI

EVENT PARTNER

WBBA

EVENT SPONSORS

COJKCooley Godward Kronish LLPFenwick & West LLP
.